F. W. Germino

发表

The Impact of Lactotripeptides on Blood Pressure Response in Stage 1 and Stage 2 Hypertensives

J. Neutel, F. W. Germino, Mako Nonaka, 2010, Journal of clinical hypertension.

The management and treatment of hypertension.

F. W. Germino, 2009, Clinical cornerstone.

Comparison of Monotherapy with Irbesartan 150 mg or Amlodipine 5 mg for Treatment of Mild-to-Moderate Hypertension

J. Neutel, David H. G. Smith, F. W. Germino, 2005, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Which Diuretic Is the Preferred Agent for Treating Essential Hypertension: Hydrochlorothiazide or Chlorthalidone?

F. W. Germino, 2012, Current Cardiology Reports.

Hypertension for the Primary Care Clinician 2010

J. Basile, M. Moser, L. Kuritzky, 2010 .

J. Neutel, David H. G. Smith, F. W. Germino, 2001 .

Masked Hypertension: Does It Lead to CVD or CKD?

F. W. Germino, 2015 .

Unmasking Masked Hypertension

F. W. Germino, 2014, Journal of clinical hypertension.

The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl.

S. Glasser, F. Faas, R. Dibianco, 1996, The American journal of cardiology.

Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.

F. W. Germino, 2009, Clinical therapeutics.

Therapeutic Inertia and Measurement Inertia in Hypertension: A Call to Action

F. W. Germino, 2013, Journal of clinical hypertension.

Olmesartan Medoxomil-Based Antihypertensive Therapy Evaluated by Ambulatory Blood Pressure Monitoring

J. Neutel, S. Chrysant, F. W. Germino, 2012, American Journal of Cardiovascular Drugs.

Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.

J. Neutel, S. Chrysant, F. W. Germino, 2012, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I–II hypertension

F. W. Germino, Yuhua Lin, Vojislav Pejović, 2012, Therapeutic advances in cardiovascular disease.

Noninsulin treatment of type 2 diabetes mellitus in geriatric patients: a review.

F. W. Germino, 2011, Clinical therapeutics.

History and Justification of a National Blood Pressure Measurement Validated Device Listing

Beverly B. Green, Raymond R. Townsend, Anthony J. Viera, 2019, Hypertension.

Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension

J. Neutel, J. Maa, F. W. Germino, 2012, American Journal of Cardiovascular Drugs.

JNC 8: expectations, challenges, and wishes--a primary care perspective.

F. W. Germino, 2009, Journal of clinical hypertension.

Efficacy and Safety of Olmesartan Medoxomil in Patients with Stage 1 Hypertension: Blood Pressure Lowering and Goal Achievement

F. W. Germino, 2010, Postgraduate medicine.

Chocolate Is Good for Me, Right?

F. W. Germino, 2014, Journal of clinical hypertension.